BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou J, Yi Y, Wang C, Su C, Luo Y. Identification of a 3-mRNA signature as a novel potential prognostic biomarker in patients with ovarian serous cystadenocarcinoma in G2 and G3. Oncol Lett 2019;18:3545-52. [PMID: 31579405 DOI: 10.3892/ol.2019.10701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang D, Li Y, Yang S, Wang M, Yao J, Zheng Y, Deng Y, Li N, Wei B, Wu Y, Zhai Z, Dai Z, Kang H. Identification of a glycolysis-related gene signature for survival prediction of ovarian cancer patients. Cancer Med 2021;10:8222-37. [PMID: 34609082 DOI: 10.1002/cam4.4317] [Reference Citation Analysis]
2 Wang L, Li X. Identification of an energy metabolism‑related gene signature in ovarian cancer prognosis. Oncol Rep 2020;43:1755-70. [PMID: 32186777 DOI: 10.3892/or.2020.7548] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
3 Zhao X, He M. Comprehensive pathway-related genes signature for prognosis and recurrence of ovarian cancer. PeerJ 2020;8:e10437. [PMID: 33344083 DOI: 10.7717/peerj.10437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Liu J, Lv D, Wang X, Wang R, Li X. Systematic Profiling of Alternative Splicing Events in Ovarian Cancer. Front Oncol 2021;11:622805. [PMID: 33763357 DOI: 10.3389/fonc.2021.622805] [Reference Citation Analysis]